HCW Biologics annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
HCW Biologics Capital Expenditures (CapEx) Growth & History (HCWB)
HCW Biologics's capital expenditures (capex) was $0 for fiscal 2025.
View full HCW Biologics company overviewHCW Biologics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | −$261,617 | — |
| 2024 | 2024-12-31 | $261,617 | −$5.9M | −95.78% |
| 2023 | 2023-12-31 | $6.2M | −$4.1M | −39.63% |
| 2022 | 2022-12-31 | $10.3M | $10.2M | +21640.32% |
| 2021 | 2021-12-31 | $47,263 | −$139,419 | −74.68% |
| 2020 | 2020-12-31 | $186,682 | — | — |
HCW Biologics quarterly capital expenditures (capex)
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $0 | −$113,412 | — |
| Q3 2025 | 2025-09-30 | $0 | −$37,063 | — |
| Q2 2025 | 2025-06-30 | $0 | −$18,567 | — |
| Q1 2025 | 2025-03-31 | $0 | −$129,709 | — |
| Q4 2024 | 2024-12-31 | $113,412 | −$3.6M | −96.95% |
| Q3 2024 | 2024-09-30 | $37,063 | −$592,987 | −94.12% |
| Q2 2024 | 2024-06-30 | $18,567 | −$1.5M | −98.81% |
| Q1 2024 | 2024-03-31 | $129,709 | −$170,676 | −56.82% |
| Q4 2023 | 2023-12-31 | $3.7M | $3.6M | +5309.54% |
| Q3 2023 | 2023-09-30 | $630,050 | −$9.5M | −93.80% |
| Q2 2023 | 2023-06-30 | $1.6M | $1.5M | +11959.46% |
| Q1 2023 | 2023-03-31 | $300,385 | $276,831 | +1175.30% |
| Q4 2022 | 2022-12-31 | $68,687 | $48,835 | +246.00% |
| Q3 2022 | 2022-09-30 | $10.2M | $10.2M | +246027.30% |
| Q2 2022 | 2022-06-30 | $12,907 | $12,907 | — |
| Q1 2022 | 2022-03-31 | $23,554 | $275 | +1.18% |
| Q4 2021 | 2021-12-31 | $19,852 | — | — |
| Q3 2021 | 2021-09-30 | $4,132 | −$101,083 | −96.07% |
| Q2 2021 | 2021-06-30 | $0 | — | — |
| Q1 2021 | 2021-03-31 | $23,279 | — | — |
| Q3 2020 | 2020-09-30 | $105,215 | — | — |
HCW Biologics capital expenditures (capex) trends
Over the last five fiscal years, HCW Biologics's capital expenditures (capex) decreased from $186,682 to $0, a change of −$186,682. The latest reported quarter, Q4 2025, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCW Biologics source filings ↗